Literature DB >> 11486010

Expression of the three human major histocompatibility complex class II isotypes exhibits a differential dependence on the transcription factor RFXAP.

M Peretti1, J Villard, E Barras, M Zufferey, W Reith.   

Abstract

Major histocompatibility complex class II (MHCII) molecules play a pivotal role in the immune system because they direct the development and activation of CD4(+) T cells. There are three human MHCII isotypes, HLA-DR, HLA-DQ, and HLA-DP. Key transcription factors controlling MHCII genes have been identified by virtue of the fact that they are mutated in a hereditary immunodeficiency resulting from a lack of MHCII expression. RFXAP-one of the factors affected in this disease-is a subunit of RFX, a DNA-binding complex that recognizes the X box present in all MHCII promoters. To facilitate identification of conserved regions in RFXAP, we isolated the mouse gene. We then delimited conserved domains required to restore endogenous MHCII expression in cell lines lacking a functional RFXAP gene. Surprisingly, we found that 80% of RFXAP is dispensable for the reactivation of DR expression. Only a short C-terminal segment of the protein is essential for this isotype. In contrast, optimal expression of DQ and DP requires a larger C-terminal segment. These results define an RFXAP domain with an MHCII isotype-specific function. Expression of the three MHCII isotypes exhibits a differential requirement for this domain. We show that this is due to a differential dependence on this domain for promoter occupation and recruitment of the coactivator CIITA in vivo.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11486010      PMCID: PMC87290          DOI: 10.1128/MCB.21.17.5699-5709.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  49 in total

Review 1.  Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins.

Authors:  P J Mitchell; R Tjian
Journal:  Science       Date:  1989-07-28       Impact factor: 47.728

2.  Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: identification of a class of bipartite nuclear targeting sequence.

Authors:  J Robbins; S M Dilworth; R A Laskey; C Dingwall
Journal:  Cell       Date:  1991-02-08       Impact factor: 41.582

3.  A rapid and convenient method for isolation of nuclear, cytoplasmic and total cellular RNA.

Authors:  M Wilkinson
Journal:  Nucleic Acids Res       Date:  1988-11-25       Impact factor: 16.971

4.  Inherited immunodeficiency with a defect in a major histocompatibility complex class II promoter-binding protein differs in the chromatin structure of the HLA-DRA gene.

Authors:  P Gönczy; W Reith; E Barras; B Lisowska-Grospierre; C Griscelli; M R Hadam; B Mach
Journal:  Mol Cell Biol       Date:  1989-01       Impact factor: 4.272

5.  Revertants from the HLA class II regulatory mutant 6.1.6: implications for the regulation of Ia gene expression.

Authors:  F Levine; D Pious
Journal:  J Immunol       Date:  1984-02       Impact factor: 5.422

6.  MHC class II regulatory factor RFX has a novel DNA-binding domain and a functionally independent dimerization domain.

Authors:  W Reith; C Herrero-Sanchez; M Kobr; P Silacci; C Berte; E Barras; S Fey; B Mach
Journal:  Genes Dev       Date:  1990-09       Impact factor: 11.361

7.  Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X.

Authors:  W Reith; S Satola; C H Sanchez; I Amaldi; B Lisowska-Grospierre; C Griscelli; M R Hadam; B Mach
Journal:  Cell       Date:  1988-06-17       Impact factor: 41.582

8.  The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer.

Authors:  V Kumar; P Chambon
Journal:  Cell       Date:  1988-10-07       Impact factor: 41.582

9.  Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes.

Authors:  M Kozak
Journal:  Cell       Date:  1986-01-31       Impact factor: 41.582

10.  Ribosomal initiation from an ACG codon in the Sendai virus P/C mRNA.

Authors:  J Curran; D Kolakofsky
Journal:  EMBO J       Date:  1988-01       Impact factor: 11.598

View more
  14 in total

1.  Novel mutations in the RFXANK gene: RFX complex containing in-vitro-generated RFXANK mutant binds the promoter without transactivating MHC II.

Authors:  Wojciech Wiszniewski; Marie-Claude Fondaneche; Pascale Louise-Plence; Ada Prochnicka-Chalufour; Françoise Selz; Cappucine Picard; Françoise Le Deist; Jean-François Eliaou; Alain Fischer; Barbara Lisowska-Grospierre
Journal:  Immunogenetics       Date:  2003-01-16       Impact factor: 2.846

2.  Use of bimolecular fluorescence complementation to demonstrate transcription factor interaction in nuclei of living cells from the filamentous fungus Acremonium chrysogenum.

Authors:  Birgit Hoff; Ulrich Kück
Journal:  Curr Genet       Date:  2004-11-30       Impact factor: 3.886

3.  New functions of the major histocompatibility complex class II-specific transcription factor RFXANK revealed by a high-resolution mutagenesis study.

Authors:  Michal Krawczyk; Krzysztof Masternak; Madeleine Zufferey; Emmanuèle Barras; Walter Reith
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

4.  Coordinate loss of MHC class II expression in the diffuse large B cell lymphoma cell line OCI-Ly2 is due to a novel mutation in RFX-AP.

Authors:  Meghan Bushway; Kelly A Cycon; Kathleen Mulvaney; Shawn P Murphy
Journal:  Immunogenetics       Date:  2009-12-19       Impact factor: 2.846

5.  Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.

Authors:  Suhani Thakker; Pravinkumar Purushothaman; Namrata Gupta; Shanthan Challa; Qiliang Cai; Subhash C Verma
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

6.  Solution structure of the heterotrimeric complex between the interaction domains of RFX5 and RFXAP from the RFX gene regulatory complex.

Authors:  Kholiswa M Laird; LaTese L Briggs; Jeremy M Boss; Michael F Summers; Colin W Garvie
Journal:  J Mol Biol       Date:  2010-08-21       Impact factor: 5.469

7.  Formation of the RFX gene regulatory complex induces folding of the interaction domain of RFXAP.

Authors:  LaTese Briggs; Kholiswa Laird; Jeremy M Boss; Colin W Garvie
Journal:  Proteins       Date:  2009-08-15

8.  A strategy to determine HLA class II restriction broadly covering the DR, DP, and DQ allelic variants most commonly expressed in the general population.

Authors:  Denise M McKinney; Scott Southwood; Denise Hinz; Carla Oseroff; Cecilia S Lindestam Arlehamn; Veronique Schulten; Randy Taplitz; David Broide; Willem A Hanekom; Thomas J Scriba; Robert Wood; Rafeul Alam; Bjoern Peters; John Sidney; Alessandro Sette
Journal:  Immunogenetics       Date:  2013-02-08       Impact factor: 2.846

Review 9.  Inhibition of MHC II gene transcription by nitric oxide and antioxidants.

Authors:  Olivier Harari; James K Liao
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

10.  Membranal and Blood-Soluble HLA Class II Peptidome Analyses Using Data-Dependent and Independent Acquisition.

Authors:  Danilo Ritz; Emiliano Sani; Hanna Debiec; Pierre Ronco; Dario Neri; Tim Fugmann
Journal:  Proteomics       Date:  2018-03-14       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.